Biggest News Aggregation in the World
📰 Al0891 News

Al0891 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Al0891. Real-time updates on events, politics, business and more.

Press Release: Basilea reports preclinical data on oncology drug candidates BAL0891, derazantinib and lisavanbulin at AACR Annual Meeting

Basel, Switzerland, April 13, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer
Basel Stadt United States M El Shemerly F Bertoni Avanbulin Laurenz Kellenberger P Mcsheehy Derazantinib

Basilea Pharmaceutica AG: Basilea reports preclinical data on anti-cancer activity of novel oncology drug candidate BAL0891 at ESMO TAT congress

Press Release Basel, Switzerland, March 08, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious
Basel Stadt Nils Schr Laurenz Kellenberger European Society Of Medical Oncology Head Of Corporate Communications Investor Relations Basilea Pharmaceutica Ltd

Basilea Pharmaceutica AG: Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891

Phase 1 study in patients with advanced solid tumors planned to start in the first quarter of 2022 Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 17, 2021 Basilea Pharmaceutica
Basel Stadt Nils Schr Laurenz Kellenberger Head Of Corporate Communications Investor Relations Drug Administration Swiss Exchange

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science